Rep. Waxman raises questions about the effectiveness and credibility of USDA's response to mad cow disease, citing an audit by the USDA Inspector General that finds systemic deficiencies in the Department's surveillance plan and new evidence that USDA misled the public in the wake of the detection of an infected cow in Washington State.
Rep. Waxman releases a preliminary audit of the Development Fund for Iraq by KPMG that finds serious deficiencies in U.S. accounting practices and criticizes CPA officials for failing to cooperate with the U.N.-approved audit. Rep. Waxman asks Chairman Davis to subpoena documents relating to U.S. expenditures from the fund.
A new analysis by Rep. Waxman reveals that despite its public promises of quick action, the Administration is unnecessarily delaying the rapid approval of combination HIV therapies for use in Africa and other developing regions.
Rep. Waxman and Senator Collins release a Special Investigations Division report revealing that nearly 2,000 youth are incarcerated each day because community mental health services are unavailable.
The Washington Post has published Rep. Waxman's essay on the abrupt reversal in Congress's approach to oversight.
Reps. Waxman and Slaughter reveal that the pharmacy information on the Medicare.gov web contains multiple errors, incorrectly identifying the Medicare drug cards that can be used at many pharmacies.
Rep. Waxman urges the pharmaceutical manufacturer to reconsider its decision to withdraw from a major NIH-sponsored HIV clinical trial, an action that is undermining efforts to determine how to treat millions of people infected with HIV around the world.
Citing a new GAO report, Rep. Waxman urges the President to address the growing threat of cigarette smuggling by making ratification of the Framework Convention on Tobacco Control an urgent priority.
Rep. Waxman, Sen. Grassley, Sen. Edwards, and Sen. Bond write HHS about its recent admission that nursing home staffing level data is unreliable – data nonetheless posted to the HHS website that the department encourages families to use to make nursing home decisions.
A new HHS policy requires the World Health Organization to submit all requests for expert scientific advice to political officials at HHS who pick which federal scientists will be permitted to respond. The new policy and two recent Administration decisions to withdraw federal scientists from major international health conferences are part of a disturbing pattern of political interference in global health issues.
Reps. Waxman, Cooper, Allen, Grijalva, E.B. Johnson, McCollum, Schakowsky, Solis, and 172 other members of Congress urge EPA to issue a rule on mercury emissions that meets the requirements of federal law and acts decisively to address the urgent threat that mercury poses to the nation’s public health.
Rep. Waxman, alongside Democratic Leader Pelosi, Armed Services Ranking Member Skelton, and nine other congressional leaders, introduces legislation to create a select committee in the House to investigate the abuses of detainees held in U.S. custody in Abu Ghraib prison and elsewhere.
Chairman Davis and Rep. Waxman introduce H.R. 4433, legislation that would give FDA strong authority to regulate tobacco products. The bill addressses youth smoking, requires a review of scientific evidence before "reduced risk" tobacco products could be marketed, and provides the agency authority to control the content of tobacco products.
New data, released by the State Department to correct serious mistakes in the initial Patterns of Global Terrorism 2003 report, shows a major increase in deaths and injuries in terrorist attacks in 2003, with “significant” attacks reaching a 20-year high.
In a letter to Senate Majority Leader Frist and Speaker Hastert, Senate Democratic Leader Daschle, House Democratic Leader Pelosi, Rep. Waxman, and ten other congressional leaders call the failure to investigate the Administration’s withholding of Medicare cost estimates from Congress a gross abdication of Congress’ constitutional oversight responsibility. In a letter to the President, the members ask the President to provide complete answers to straightforward questions on his role in the matter.
Responding to concerns from the scientific community, Rep. Waxman asks GAO to review the recent CDC estimate of the number of deaths attributable to obesity.
In a letter to HHS, Democratic Leader Pelosi, Democratic Whip Hoyer, Rep. Waxman, Rep. Frank, Rep. Sherrod Brown, Del. Christensen, Rep. Lee and Rep. Baldwin make Secretary Thompson aware of his own agency's conclusion that an HIV/AIDS drug program for Americans lacking adequate health insurance urgently needs significantly more funding.
A new report released by Rep. Waxman finds that, under the Administration’s proposed energy policies, U.S. dependence on foreign oil will continue to increase markedly into the foreseeable future.
Five former Halliburton employees and one former executive of a Halliburton subcontractor describe egregious examples of waste, fraud, and abuse involving Halliburton’s Iraq contracts. A new Pentagon audit finds serious deficiencies in Halliburton’s billing practices.
Rep. Waxman discloses that a senior Defense Department official briefed I. Lewis “Scooter” Libby, the Vice President’s chief of staff, and other senior Administration officials in October 2002 about the Department’s proposal to award lucrative Iraq contracts to Halliburton. This new information appears to contradict the Vice President’s repeated assertions that he and his staff were not informed prior to the award of the Halliburton contracts.
Rep. Waxman writes the Pharmaceutical Research and Manufacturers of America regarding the failure of many pharmaceutical companies to submit information on their cancer clinical trials to www.clinicaltrials.gov – despite a federal law requiring them to do so.
Democratic committee leaders inform the President of their determination to investigate the allegations of prison abuses in Iraq, Afghanistan, and Guantanamo Bay, and ask the President for assistance in obtaining key documents.
An analysis released by Rep. Waxman finds that the Administration’s claims that competition would reduce drug prices under the new Medicare discount cards have yet to materialize.
In a letter to Secretary Rumsfeld, Rep. Waxman raises questions about the legality of the decision to award Halliburton a task order to develop contingency plans for Iraq’s oil infrastructure, citing new GAO findings that Secretary Rumsfeld’s office overruled Army officials who questioned the issuance of the task order.
A new report released by Rep. Waxman shows that the Bush Administration awarded $107 billion in sole-source and other noncompetitive contracts in fiscal year 2003, an increase of 60% compared to the last year of the Clinton Administration.
Displaying Items 851 to 875 of 1318:
[1] • [2] • [3] • [4] • [5] • [6] • [7] • [8] • [9] • [10] • [11] • [12] • [13] • [14] • [15] • [16] • [17] • [18] • [19] • [20] • [21] • [22] • [23] • [24] • [25] • [26] • [27] • [28] • [29] • [30] • [31] • [32] • [33] • [34] • [35] • [36] • [37] • [38] • [39] • [40] • [41] • [42] • [43] • [44] • [45] • [46] • [47] • [48] • [49] • [50] • [51] • [52] • [53]